Epac2 activation mediates glucagon‐induced glucogenesis in primary rat hepatocytes

ABSTRACT Aims/Introduction Glucagon plays an essential role in hepatic glucogenesis by enhancing glycogen breakdown, inducing gluconeogenesis, and suppressing glycogenesis. Moreover, glucagon increases cyclic adenosine monophosphate (cAMP) levels, thereby activating protein kinase A (PKA) and cAMP g...

Full description

Bibliographic Details
Main Authors: Yusuke Shiozaki‐Takagi, Nobuaki Ozaki, Yukiyasu Toyoda
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Journal of Diabetes Investigation
Subjects:
Online Access:https://doi.org/10.1111/jdi.14142
_version_ 1797234159054225408
author Yusuke Shiozaki‐Takagi
Nobuaki Ozaki
Yukiyasu Toyoda
author_facet Yusuke Shiozaki‐Takagi
Nobuaki Ozaki
Yukiyasu Toyoda
author_sort Yusuke Shiozaki‐Takagi
collection DOAJ
description ABSTRACT Aims/Introduction Glucagon plays an essential role in hepatic glucogenesis by enhancing glycogen breakdown, inducing gluconeogenesis, and suppressing glycogenesis. Moreover, glucagon increases cyclic adenosine monophosphate (cAMP) levels, thereby activating protein kinase A (PKA) and cAMP guanine nucleotide exchange factor (also known as Epac). Although the function of PKA in the liver has been studied extensively, the function of hepatic Epac is poorly understood. The aim of this study was to elucidate the role of Epac in mediating the action of glucagon on the hepatocytes. Materials and Methods Epac mRNA and protein expression, localization, and activity in the hepatocytes were analyzed by reverse transcription polymerase chain reaction, western blotting, immunofluorescence staining, and Rap1 activity assay, respectively. Additionally, we investigated the effects of an Epac‐specific activator, 8‐CPT, and an Epac‐specific inhibitor, ESI‐05, on glycogen metabolism in isolated rat hepatocytes. Further mechanisms of glycogen metabolism were evaluated by examining glucokinase (GK) translocation and mRNA expression of gluconeogenic enzymes. Results Epac2, but not Epac1, was predominantly expressed in the liver. Moreover, 8‐CPT inhibited glycogen accumulation and GK translocation and enhanced the mRNA expression of gluconeogenic enzymes. ESI‐05 failed to reverse glucagon‐induced suppression of glycogen storage and partially inhibited glucagon‐induced GK translocation and the mRNA expression of gluconeogenic enzymes. Conclusions Epac signaling plays a role in mediating the glucogenic action of glucagon in the hepatocytes.
first_indexed 2024-04-24T16:27:38Z
format Article
id doaj.art-0808263fc07f490bb97dc27e761b4477
institution Directory Open Access Journal
issn 2040-1116
2040-1124
language English
last_indexed 2024-04-24T16:27:38Z
publishDate 2024-04-01
publisher Wiley
record_format Article
series Journal of Diabetes Investigation
spelling doaj.art-0808263fc07f490bb97dc27e761b44772024-03-30T10:00:09ZengWileyJournal of Diabetes Investigation2040-11162040-11242024-04-0115442943610.1111/jdi.14142Epac2 activation mediates glucagon‐induced glucogenesis in primary rat hepatocytesYusuke Shiozaki‐Takagi0Nobuaki Ozaki1Yukiyasu Toyoda2Research Center of Health, Physical Fitness and Sports Nagoya University Nagoya JapanResearch Center of Health, Physical Fitness and Sports Nagoya University Nagoya JapanDepartment of Pathobiochemistry, Faculty of Pharmacy Meijo University Nagoya JapanABSTRACT Aims/Introduction Glucagon plays an essential role in hepatic glucogenesis by enhancing glycogen breakdown, inducing gluconeogenesis, and suppressing glycogenesis. Moreover, glucagon increases cyclic adenosine monophosphate (cAMP) levels, thereby activating protein kinase A (PKA) and cAMP guanine nucleotide exchange factor (also known as Epac). Although the function of PKA in the liver has been studied extensively, the function of hepatic Epac is poorly understood. The aim of this study was to elucidate the role of Epac in mediating the action of glucagon on the hepatocytes. Materials and Methods Epac mRNA and protein expression, localization, and activity in the hepatocytes were analyzed by reverse transcription polymerase chain reaction, western blotting, immunofluorescence staining, and Rap1 activity assay, respectively. Additionally, we investigated the effects of an Epac‐specific activator, 8‐CPT, and an Epac‐specific inhibitor, ESI‐05, on glycogen metabolism in isolated rat hepatocytes. Further mechanisms of glycogen metabolism were evaluated by examining glucokinase (GK) translocation and mRNA expression of gluconeogenic enzymes. Results Epac2, but not Epac1, was predominantly expressed in the liver. Moreover, 8‐CPT inhibited glycogen accumulation and GK translocation and enhanced the mRNA expression of gluconeogenic enzymes. ESI‐05 failed to reverse glucagon‐induced suppression of glycogen storage and partially inhibited glucagon‐induced GK translocation and the mRNA expression of gluconeogenic enzymes. Conclusions Epac signaling plays a role in mediating the glucogenic action of glucagon in the hepatocytes.https://doi.org/10.1111/jdi.14142EPACGlucagonGlucogenic action
spellingShingle Yusuke Shiozaki‐Takagi
Nobuaki Ozaki
Yukiyasu Toyoda
Epac2 activation mediates glucagon‐induced glucogenesis in primary rat hepatocytes
Journal of Diabetes Investigation
EPAC
Glucagon
Glucogenic action
title Epac2 activation mediates glucagon‐induced glucogenesis in primary rat hepatocytes
title_full Epac2 activation mediates glucagon‐induced glucogenesis in primary rat hepatocytes
title_fullStr Epac2 activation mediates glucagon‐induced glucogenesis in primary rat hepatocytes
title_full_unstemmed Epac2 activation mediates glucagon‐induced glucogenesis in primary rat hepatocytes
title_short Epac2 activation mediates glucagon‐induced glucogenesis in primary rat hepatocytes
title_sort epac2 activation mediates glucagon induced glucogenesis in primary rat hepatocytes
topic EPAC
Glucagon
Glucogenic action
url https://doi.org/10.1111/jdi.14142
work_keys_str_mv AT yusukeshiozakitakagi epac2activationmediatesglucagoninducedglucogenesisinprimaryrathepatocytes
AT nobuakiozaki epac2activationmediatesglucagoninducedglucogenesisinprimaryrathepatocytes
AT yukiyasutoyoda epac2activationmediatesglucagoninducedglucogenesisinprimaryrathepatocytes